- Record: found
- Abstract: found
- Article: not found
Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial.
Henry R Black
1 ,
William J Elliott ,
Gregory Grandits ,
Patricia Grambsch ,
Tracy Lucente ,
William B White ,
James D Neaton ,
Richard H Grimm ,
Lennart Hansson ,
Yves Lacourciere ,
James Muller ,
Peter Sleight ,
Michael A Weber ,
Gordon Williams ,
Janet Wittes ,
Alberto Zanchetti ,
Robert J Anders
April 24 2003
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Hypertensive patients are often given a calcium antagonist to reduce cardiovascular disease risk, but the benefit compared with other drug classes is controversial.
Related collections
Author and article information
Comments
Comment on this article
scite_